aluates Reports

$ 0.0

Automative

Global Alzheimer's Disease Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-35R2945

Global Alzheimer s Disease Market Insights and Forecast to 2028

BUY CHAPTERS

Global Alzheimer's Disease Market Research Report 2025

Code: QYRE-Auto-35R2945

Report

September 2025

Pages:79

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Novartis

Daiichi Sankyo

Merz Pharma

Pfizer Inc

Johnson & Johnson

Lundbeck

Allergan plc

Eisai Co Ltd

Alzheimer's Disease Market Size

The global market for Alzheimer's Disease was valued at US$ 3730 million in the year 2024 and is projected to reach a revised size of US$ 4134 million by 2031, growing at a CAGR of 1.5% during the forecast period.

Alzheimer's Disease Market

Alzheimer"s disease (AD), also referred to simply as Alzheimer"s, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia.

The major players in global Alzheimer’s Disease Drug market include Allergan, Eisai, Novartis, Daiichi Sankyo, Merz Pharma, Pfizer, Johnson & Johnson, Lundbeck, etc. The top 3 players hold over 60% of global shares. Europe and North America are main markets, they occupy over 70% of the global market. Memantine and Donepezil are the main types, with a share about 70%. Early to Moderate Stages is the key application, which covers over 55% shares.

This report aims to provide a comprehensive presentation of the global market for Alzheimer's Disease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alzheimer's Disease.

The Alzheimer's Disease market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Alzheimer's Disease market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Alzheimer's Disease companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Alzheimer's Disease Market Report

Report Metric	Details
Report Name	Alzheimer's Disease Market
Accounted market size in year	US$ 3730 million
Forecasted market size in 2031	US$ 4134 million
CAGR	1.5%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Donepezil Memantine Rivastigmine
Segment by Application	Early to Moderate Stages Moderate to Severe Stages
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Allergan, Eisai, Novartis, Daiichi Sankyo, Merz Pharma, Pfizer, Johnson & Johnson, Lundbeck
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Alzheimer's Disease company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Alzheimer's Disease Market growing?

Ans: The Alzheimer's Disease Market witnessing a CAGR of 1.5% during the forecast period 2025-2031.

What is the Alzheimer's Disease Market size in 2031?

Ans: The Alzheimer's Disease Market size in 2031 will be US$ 4134 million.

What is the market share of major companies in Alzheimer's Disease Market?

Ans: The top 3 players hold over 60% of global shares.

What is the Alzheimer's Disease Market share by type?

Ans: Memantine and Donepezil are the main types, with a share about 70%.

What is the Alzheimer's Disease Market share by application?

Ans: Early to Moderate Stages is the key application, which covers over 55% shares.

Who are the main players in the Alzheimer's Disease Market report?

Ans: The main players in the Alzheimer's Disease Market are Allergan, Eisai, Novartis, Daiichi Sankyo, Merz Pharma, Pfizer, Johnson & Johnson, Lundbeck

What are the Application segmentation covered in the Alzheimer's Disease Market report?

Ans: The Applications covered in the Alzheimer's Disease Market report are Early to Moderate Stages, Moderate to Severe Stages

What are the Type segmentation covered in the Alzheimer's Disease Market report?

Ans: The Types covered in the Alzheimer's Disease Market report are Donepezil, Memantine, Rivastigmine

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Alzheimer's Disease Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Donepezil

1.2.3 Memantine

1.2.4 Rivastigmine

1.3 Market by Application

1.3.1 Global Alzheimer's Disease Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Early to Moderate Stages

1.3.3 Moderate to Severe Stages

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Alzheimer's Disease Market Perspective (2020-2031)

2.2 Global Alzheimer's Disease Growth Trends by Region

2.2.1 Global Alzheimer's Disease Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Alzheimer's Disease Historic Market Size by Region (2020-2025)

2.2.3 Alzheimer's Disease Forecasted Market Size by Region (2026-2031)

2.3 Alzheimer's Disease Market Dynamics

2.3.1 Alzheimer's Disease Industry Trends

2.3.2 Alzheimer's Disease Market Drivers

2.3.3 Alzheimer's Disease Market Challenges

2.3.4 Alzheimer's Disease Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Alzheimer's Disease Players by Revenue

3.1.1 Global Top Alzheimer's Disease Players by Revenue (2020-2025)

3.1.2 Global Alzheimer's Disease Revenue Market Share by Players (2020-2025)

3.2 Global Alzheimer's Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Alzheimer's Disease Revenue

3.4 Global Alzheimer's Disease Market Concentration Ratio

3.4.1 Global Alzheimer's Disease Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Alzheimer's Disease Revenue in 2024

3.5 Global Key Players of Alzheimer's Disease Head office and Area Served

3.6 Global Key Players of Alzheimer's Disease, Product and Application

3.7 Global Key Players of Alzheimer's Disease, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Alzheimer's Disease Breakdown Data by Type

4.1 Global Alzheimer's Disease Historic Market Size by Type (2020-2025)

4.2 Global Alzheimer's Disease Forecasted Market Size by Type (2026-2031)

5 Alzheimer's Disease Breakdown Data by Application

5.1 Global Alzheimer's Disease Historic Market Size by Application (2020-2025)

5.2 Global Alzheimer's Disease Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Alzheimer's Disease Market Size (2020-2031)

6.2 North America Alzheimer's Disease Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Alzheimer's Disease Market Size by Country (2020-2025)

6.4 North America Alzheimer's Disease Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Alzheimer's Disease Market Size (2020-2031)

7.2 Europe Alzheimer's Disease Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Alzheimer's Disease Market Size by Country (2020-2025)

7.4 Europe Alzheimer's Disease Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Alzheimer's Disease Market Size (2020-2031)

8.2 Asia-Pacific Alzheimer's Disease Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Alzheimer's Disease Market Size by Region (2020-2025)

8.4 Asia-Pacific Alzheimer's Disease Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Alzheimer's Disease Market Size (2020-2031)

9.2 Latin America Alzheimer's Disease Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Alzheimer's Disease Market Size by Country (2020-2025)

9.4 Latin America Alzheimer's Disease Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Alzheimer's Disease Market Size (2020-2031)

10.2 Middle East & Africa Alzheimer's Disease Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Alzheimer's Disease Market Size by Country (2020-2025)

10.4 Middle East & Africa Alzheimer's Disease Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Allergan

11.1.1 Allergan Company Details

11.1.2 Allergan Business Overview

11.1.3 Allergan Alzheimer's Disease Introduction

11.1.4 Allergan Revenue in Alzheimer's Disease Business (2020-2025)

11.1.5 Allergan Recent Development

11.2 Eisai

11.2.1 Eisai Company Details

11.2.2 Eisai Business Overview

11.2.3 Eisai Alzheimer's Disease Introduction

11.2.4 Eisai Revenue in Alzheimer's Disease Business (2020-2025)

11.2.5 Eisai Recent Development

11.3 Novartis

11.3.1 Novartis Company Details

11.3.2 Novartis Business Overview

11.3.3 Novartis Alzheimer's Disease Introduction

11.3.4 Novartis Revenue in Alzheimer's Disease Business (2020-2025)

11.3.5 Novartis Recent Development

11.4 Daiichi Sankyo

11.4.1 Daiichi Sankyo Company Details

11.4.2 Daiichi Sankyo Business Overview

11.4.3 Daiichi Sankyo Alzheimer's Disease Introduction

11.4.4 Daiichi Sankyo Revenue in Alzheimer's Disease Business (2020-2025)

11.4.5 Daiichi Sankyo Recent Development

11.5 Merz Pharma

11.5.1 Merz Pharma Company Details

11.5.2 Merz Pharma Business Overview

11.5.3 Merz Pharma Alzheimer's Disease Introduction

11.5.4 Merz Pharma Revenue in Alzheimer's Disease Business (2020-2025)

11.5.5 Merz Pharma Recent Development

11.6 Pfizer

11.6.1 Pfizer Company Details

11.6.2 Pfizer Business Overview

11.6.3 Pfizer Alzheimer's Disease Introduction

11.6.4 Pfizer Revenue in Alzheimer's Disease Business (2020-2025)

11.6.5 Pfizer Recent Development

11.7 Johnson & Johnson

11.7.1 Johnson & Johnson Company Details

11.7.2 Johnson & Johnson Business Overview

11.7.3 Johnson & Johnson Alzheimer's Disease Introduction

11.7.4 Johnson & Johnson Revenue in Alzheimer's Disease Business (2020-2025)

11.7.5 Johnson & Johnson Recent Development

11.8 Lundbeck

11.8.1 Lundbeck Company Details

11.8.2 Lundbeck Business Overview

11.8.3 Lundbeck Alzheimer's Disease Introduction

11.8.4 Lundbeck Revenue in Alzheimer's Disease Business (2020-2025)

11.8.5 Lundbeck Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Novartis

Daiichi Sankyo

Merz Pharma

Pfizer Inc

Johnson & Johnson

Lundbeck

Allergan plc

Eisai Co Ltd

List of Tables

Table 1. Global Alzheimer's Disease Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Donepezil

Table 3. Key Players of Memantine

Table 4. Key Players of Rivastigmine

Table 5. Global Alzheimer's Disease Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Alzheimer's Disease Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Alzheimer's Disease Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Alzheimer's Disease Market Share by Region (2020-2025)

Table 9. Global Alzheimer's Disease Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Alzheimer's Disease Market Share by Region (2026-2031)

Table 11. Alzheimer's Disease Market Trends

Table 12. Alzheimer's Disease Market Drivers

Table 13. Alzheimer's Disease Market Challenges

Table 14. Alzheimer's Disease Market Restraints

Table 15. Global Alzheimer's Disease Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Alzheimer's Disease Market Share by Players (2020-2025)

Table 17. Global Top Alzheimer's Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer's Disease as of 2024)

Table 18. Ranking of Global Top Alzheimer's Disease Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Alzheimer's Disease Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Alzheimer's Disease, Headquarters and Area Served

Table 21. Global Key Players of Alzheimer's Disease, Product and Application

Table 22. Global Key Players of Alzheimer's Disease, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Alzheimer's Disease Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Alzheimer's Disease Revenue Market Share by Type (2020-2025)

Table 26. Global Alzheimer's Disease Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Alzheimer's Disease Revenue Market Share by Type (2026-2031)

Table 28. Global Alzheimer's Disease Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Alzheimer's Disease Revenue Market Share by Application (2020-2025)

Table 30. Global Alzheimer's Disease Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Alzheimer's Disease Revenue Market Share by Application (2026-2031)

Table 32. North America Alzheimer's Disease Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Alzheimer's Disease Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Alzheimer's Disease Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Alzheimer's Disease Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Alzheimer's Disease Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Alzheimer's Disease Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Alzheimer's Disease Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Alzheimer's Disease Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Alzheimer's Disease Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Alzheimer's Disease Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Alzheimer's Disease Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Alzheimer's Disease Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Alzheimer's Disease Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Alzheimer's Disease Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Alzheimer's Disease Market Size by Country (2026-2031) & (US$ Million)

Table 47. Allergan Company Details

Table 48. Allergan Business Overview

Table 49. Allergan Alzheimer's Disease Product

Table 50. Allergan Revenue in Alzheimer's Disease Business (2020-2025) & (US$ Million)

Table 51. Allergan Recent Development

Table 52. Eisai Company Details

Table 53. Eisai Business Overview

Table 54. Eisai Alzheimer's Disease Product

Table 55. Eisai Revenue in Alzheimer's Disease Business (2020-2025) & (US$ Million)

Table 56. Eisai Recent Development

Table 57. Novartis Company Details

Table 58. Novartis Business Overview

Table 59. Novartis Alzheimer's Disease Product

Table 60. Novartis Revenue in Alzheimer's Disease Business (2020-2025) & (US$ Million)

Table 61. Novartis Recent Development

Table 62. Daiichi Sankyo Company Details

Table 63. Daiichi Sankyo Business Overview

Table 64. Daiichi Sankyo Alzheimer's Disease Product

Table 65. Daiichi Sankyo Revenue in Alzheimer's Disease Business (2020-2025) & (US$ Million)

Table 66. Daiichi Sankyo Recent Development

Table 67. Merz Pharma Company Details

Table 68. Merz Pharma Business Overview

Table 69. Merz Pharma Alzheimer's Disease Product

Table 70. Merz Pharma Revenue in Alzheimer's Disease Business (2020-2025) & (US$ Million)

Table 71. Merz Pharma Recent Development

Table 72. Pfizer Company Details

Table 73. Pfizer Business Overview

Table 74. Pfizer Alzheimer's Disease Product

Table 75. Pfizer Revenue in Alzheimer's Disease Business (2020-2025) & (US$ Million)

Table 76. Pfizer Recent Development

Table 77. Johnson & Johnson Company Details

Table 78. Johnson & Johnson Business Overview

Table 79. Johnson & Johnson Alzheimer's Disease Product

Table 80. Johnson & Johnson Revenue in Alzheimer's Disease Business (2020-2025) & (US$ Million)

Table 81. Johnson & Johnson Recent Development

Table 82. Lundbeck Company Details

Table 83. Lundbeck Business Overview

Table 84. Lundbeck Alzheimer's Disease Product

Table 85. Lundbeck Revenue in Alzheimer's Disease Business (2020-2025) & (US$ Million)

Table 86. Lundbeck Recent Development

Table 87. Research Programs/Design for This Report

Table 88. Key Data Information from Secondary Sources

Table 89. Key Data Information from Primary Sources

Table 90. Authors List of This Report

List of Figures

Figure 1. Alzheimer's Disease Picture

Figure 2. Global Alzheimer's Disease Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Alzheimer's Disease Market Share by Type: 2024 VS 2031

Figure 4. Donepezil Features

Figure 5. Memantine Features

Figure 6. Rivastigmine Features

Figure 7. Global Alzheimer's Disease Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Alzheimer's Disease Market Share by Application: 2024 VS 2031

Figure 9. Early to Moderate Stages Case Studies

Figure 10. Moderate to Severe Stages Case Studies

Figure 11. Alzheimer's Disease Report Years Considered

Figure 12. Global Alzheimer's Disease Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Alzheimer's Disease Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Alzheimer's Disease Market Share by Region: 2024 VS 2031

Figure 15. Global Alzheimer's Disease Market Share by Players in 2024

Figure 16. Global Top Alzheimer's Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer's Disease as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Alzheimer's Disease Revenue in 2024

Figure 18. North America Alzheimer's Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Alzheimer's Disease Market Share by Country (2020-2031)

Figure 20. United States Alzheimer's Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Alzheimer's Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Alzheimer's Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Alzheimer's Disease Market Share by Country (2020-2031)

Figure 24. Germany Alzheimer's Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Alzheimer's Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Alzheimer's Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Alzheimer's Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Alzheimer's Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Alzheimer's Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Alzheimer's Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Alzheimer's Disease Market Share by Region (2020-2031)

Figure 32. China Alzheimer's Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Alzheimer's Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Alzheimer's Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Alzheimer's Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Alzheimer's Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Alzheimer's Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Alzheimer's Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Alzheimer's Disease Market Share by Country (2020-2031)

Figure 40. Mexico Alzheimer's Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Alzheimer's Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Alzheimer's Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Alzheimer's Disease Market Share by Country (2020-2031)

Figure 44. Turkey Alzheimer's Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Alzheimer's Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Alzheimer's Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Allergan Revenue Growth Rate in Alzheimer's Disease Business (2020-2025)

Figure 48. Eisai Revenue Growth Rate in Alzheimer's Disease Business (2020-2025)

Figure 49. Novartis Revenue Growth Rate in Alzheimer's Disease Business (2020-2025)

Figure 50. Daiichi Sankyo Revenue Growth Rate in Alzheimer's Disease Business (2020-2025)

Figure 51. Merz Pharma Revenue Growth Rate in Alzheimer's Disease Business (2020-2025)

Figure 52. Pfizer Revenue Growth Rate in Alzheimer's Disease Business (2020-2025)

Figure 53. Johnson & Johnson Revenue Growth Rate in Alzheimer's Disease Business (2020-2025)

Figure 54. Lundbeck Revenue Growth Rate in Alzheimer's Disease Business (2020-2025)

Figure 55. Bottom-up and Top-down Approaches for This Report

Figure 56. Data Triangulation

Figure 57. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions